Adverse Events in Patients Re-Exposed to Bone Morphogenetic Protein for Spine Surgery
Authors:
- Leah Y. CarreonLCLeah Y. Carreon
- Steven D. GlassmanSGSteven D. Glassman
- Dylan C. BrockDBDylan C. Brock
- John R. DimarJDJohn R. Dimar
- Rolando M. PunoRPRolando M. Puno
- Mitchell J. CampbellMCMitchell J. Campbell
- 1 February 2008
- journal article
- Published by Wolters Kluwer Health in Spine
- Vol. 33 (4) , 391-393
Abstract
Case series from a single spine specialty clinic. This study analyzed wound related or anaphylactic adverse events in patients re-exposed to rhBMP-2. The use of recombinant bone morphogenetic protein (rhBMP-2) as a bone graft substitute is increasing. There is concern that re-exposing patients to rhBMP-2, might result in a hyper-inflammatory response causing wound problems or an allergic reaction. Ninety-six patients who had at least 2 spine surgeries using rhBMP-2 (Infuse, Medtronic Sofamor Danek, Memphis, TN) were identified. Anteroposterior surgeries, surgeries for infection and trauma were excluded. Demographic and operative data were collected from review of medical records. Surgeries were classified into primary, revision same approach and revision different approach. Logistic regression was used to control for variables associated with increased risk of complications. During the first exposure there were 90 primary fusions and 6 revisions with 2 wound infections requiring debridements and 9 minor wound problems. During the second exposure there were 25 primary fusions, 50 same approach first revisions, 16 different approach first revisions, 1 same approach second revision and 4 different approach second revisions. There were 5 wound infections, 11 minor wound problems and no allergic reactions. There was no significant difference in the number of complications between the first and second surgeries or between patients who had a second primary surgery, a revision through the same approach or through a different approach. There were no wound problems or allergic reactions among twelve patients who had a third surgery with rhBMP-2. Multiple exposures to rhBMP-2, whether for a second primary surgery, revision through the same approach or revision through a different approach does not increase the risk of a wound infections/problems or result in clinically detectable allergic reactions.Keywords
This publication has 17 references indexed in Scilit:
- Risk Factors for the Development of Perioperative Complications in Elderly Patients Undergoing Lumbar Decompression and Arthrodesis for Spinal StenosisSpine, 2007
- Increased Swelling Complications Associated With Off-Label Usage of rhBMP-2 in the Anterior Cervical SpineSpine, 2006
- Vertebral Bone Resorption After Transforaminal Lumbar Interbody Fusion With Bone Morphogenetic Protein (rhBMP-2)Journal of Spinal Disorders & Techniques, 2006
- Graft Resorption With the Use of Bone Morphogenetic Protein: Lessons From Anterior Lumbar Interbody Fusion Using Femoral Ring Allografts and Recombinant Human Bone Morphogenetic Protein-2Spine, 2006
- Resorptive Response of rhBMP2 Simulating Infection in an Anterior Lumbar Interbody Fusion With a Femoral RingJournal of Spinal Disorders & Techniques, 2006
- Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine FusionSpine, 2006
- Initial Fusion Rates With Recombinant Human Bone Morphogenetic Protein-2/Compression Resistant Matrix and a Hydroxyapatite and Tricalcium Phosphate/Collagen Carrier in Posterolateral Spinal FusionSpine, 2005
- Perioperative complications of lumbar instrumentation and fusion in patients with diabetes mellitusThe Spine Journal, 2003
- PERIOPERATIVE COMPLICATIONS OF POSTERIOR LUMBAR DECOMPRESSION AND ARTHRODESIS IN OLDER ADULTSJournal of Bone and Joint Surgery, 2003
- Is INFUSE Bone Graft Superior to Autograft Bone? An Integrated Analysis of Clinical Trials Using the LT-CAGE Lumbar Tapered Fusion DeviceJournal of Spinal Disorders & Techniques, 2003